Browse by Divisions pre August 2011

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
[tool] Add To Shelf...
Number of items: 32.

Baxendale, H.E., Davis, Z., White, H.N., Spellerberg, M.B., Stevenson, F.K. and Goldblatt, D. (2000) Immunogenetic analysis of the immune response to pneumococcal polysaccharide. European Journal of Immunology, 30, (4), 1214-1223.

Bhat, N.M., Bieber, M.M., Spellerberg, M.B., Stevenson, F.K. and Teng, N.N. (2000) Recognition of auto- and exoantigens by V4-34 gene encoded antibodies. Scandinavian Journal of Immunology, 51, (2), 134-140.

Blaydes, J. P., Craig, A. L., Wallace, M., Ball, H. M., Traynor, N. J., Gibbs, N. K. and Hupp, T. R. (2000) Synergistic activation of p53-dependent transcription by two cooperating damage recognition pathways. Oncogene, 19, (34), 3829-3839.

Blaydes, Jeremy P., Vojtesek, Borek, Bloomberg, Graham B. and Hupp, Ted R. (2000) The development and use of phospho-specific antibodies to study protein phosphorylation. Methods in Molecular Biology, 99, (II), 177-189. (doi:10.1385/1592590543).

Carayannopoulos, M.O., Potter, K. N., Li, Yong, Natvig, J. B. and Capra, J. D. (2000) Evidence that human immunoglobulin M rheumatoid factors can Be derived from the natural autoantibody pool and undergo an antigen driven immune response in which somatically mutated rheumatoid factors have lower affinities for immunoglobulin G Fc than their germline counterparts. Scandinavian Journal of Immunology, 51, (4), 327-36.

Child, J. A., Johnson, S. A., Rule, S., Smith, G. M., Morgan, G. J., Johnson, Peter W.M., Prentice, A. G., Tollerfield, S. M. and Wareham, E. (2000) FLUDAP: salvage chemotherapy for relapsed/refractory aggressive non-Hodgkin's lymphoma. Leukemia & Lymphoma, 37, (3-4), 309-317. (doi:10.3109/10428190009089431 ).

Crawley, C.R., Foran, J.M., Gupta, R. K., Rohatiner, A.Z., Summers, K., Matthews, J., Micallef, I.N., Radford, J.A., Johnson, S.A., Johnson, Peter W.M., Sweetenham, J.W. and Lister, T. A. (2000) A phase II study to evaluate the combination of fludarabine, mitoxantrone and dexamethasone (FMD) in patients with follicular lymphoma. Annals of Oncology , 11, (7), 861-865.

Davies, F. E., Rawstron, A. C., Pratt, G., Coupe, R., Clarke, D., Lubenko, A., Short, K., Perren, T. J., Selby, P. J., Maclennan, S., Major, K., Woodhead, V., Robinson, F., Child, J. A., Smith, G. M., Johnson, Peter W.M. and Morgan, G. J. (2000) Positive and negative selection to reduce tumour contamination in peripheral blood stem cell harvests. Hematological Oncology, 18, (3), 111-120. (doi:10.1002/1099-1069(200009)18:3<111::AID-HON657>3.0.CO;2-# ).

Duriez, Patrick J., Wong, Fred, Dorovini-Zis, Katerina, Shahidi, Reza and Karsan, Aly (2000) A1 functions at the mitochondria to delay endothelial apoptosis in response to tumor necrosis factor. Journal of Biological Chemistry, 275, (24), 18099-18107. (doi:10.1074/jbc.M908925199). (PMID:10849436).

Foran, J. M., Rohatiner, A.Z., Cunningham, D., Popescu, R. A., Solal-Celigny, P., Ghielmini, M., Coiffier, B., Johnson, Peter W.M., Gisselbrecht, C., Reyes, F., Radford, J. A., Bessell, E. M., Souleau, B., Benzohra, A. and Lister, T. A. (2000) European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma. Journal of Clinical Oncology, 18, (2), 317-324.

Foran, J.M., Cunningham, D., Coiffier, B., Solal-Celigny, P., Reyes, F., Ghielmini, M., Johnson, Peter W.M., Gisselbrecht, C., Bradburn, M., Matthews, J. and Lister, T. A. (2000) Treatment of mantle-cell lymphoma with Rituximab (chimeric monoclonal anti-CD20 antibody): analysis of factors associated with response. Annals of Oncology , 11, (Supplement 1), S117-S121. (doi:10.1093/annonc/11.suppl_1.S117).

Foran, J.M., Gupta, R. K., Cunningham, D., Popescu, R. A., Goldstone, A. H., Sweetenham, J.W., Pettengell, R., Johnson, Peter W.M., Bessell, E., Hancock, B., Summers, K., Hughes, J. , Rohatiner, A. Z. and Lister, T. A. (2000) A UK multicentre phase II study of rituximab (chimaeric anti-CD20 monoclonal antibody) in patients with follicular lymphoma, with PCR monitoring of molecular response. British Journal of Haematology, 109, (1), 81-88.

Garand, R., Sahota, S.S., Avet-Loiseau, H., Talmant, P., Robillard, N., Moreau, A., Gaillard, F., Stevenson, F.K. and Bataille, R. (2000) IgG-secreting lymphoplasmacytoid leukaemia: a B-cell disorder with extensively mutated VH genes undergoing Ig isotype-switching frequently associated with trisomy 12. British Journal of Haematology, 109, (1), 71-80. (doi:10.1046/j.1365-2141.2000.01971.x).

Glennie, M.J. (2000) Signalling antibodies for the treatment of neoplastic disease. Disease Markers, 16, (1-2), 63-63. (PMID:11360830).

Hamblin, T.J., Orchard, J.A., Gardiner, A., Oscier, D.G., Davis, Z. and Stevenson, F. K. (2000) Immunoglobulin V genes and CD38 expression in CLL. Blood, 95, (7), 2455-2457.

Honeychurch, Jamie, Tutt, Alison L., Heijnen, Ingmar A.F.M., van de Winkel, Jan G.J. and Glennie, Martin J. (2000) Therapeutic efficacy of FcgammaRI/CD64-directed bispecific antibodies in B-cell lymphoma. Blood, 96, (10), 3544-3552. (PMID:11071653).

Huby, Russell, Chowdhury , Ferdousi and Lombardi, Giovanna (2000) Rafts for antigen presentation? Nature Immunology, 2, (1), 3. (doi:10.1038/83154). (PMID:11135565 ).

Lucassen, Anneke M. and Houlston, Richard S. (2000) Clinical geneticists' attitudes and practice towards testing for breast cancer susceptibility genes. Journal of Medical Genetics, 37, (2), 157-160. (doi:10.1136/jmg.37.2.157). (PMID:10712111).

MacCarthy-Morrogh, Lucy, Wood, Lynn, Brimmell, Matthew, Johnson, Peter W. and Packham, Graham (2000) Identification of a novel human BCL-X promoter and exon. Oncogene, 19, (48), 5534-5538.

MacCarthy-Morrogh, Lucy., Townsend, Paul A., Purohit, Atul., Hejaz, Hatem A.M., Potter, Barry V.L., Reed, Michael J. and Packham, Graham. (2000) Differential effects of estrone and estrone-3-O-sulfamate derivatives on mitotic. Arrest apoptosis, and microtubule assembly in human breast cancer cells. Cancer Research, 60, 5441-5450.

Ottensmeier, C.H. and Stevenson, F.K. (2000) Isotype switch variants reveal clonally related subpopulations in diffuse large B-cell lymphoma. Blood, 96, (7), 2550-2556.

Potter, K.N. (2000) Molecular characterization of cold agglutinins. Transfusion Science, 22, (1-2), 113-119. (doi:10.1016/S0955-3886(00)00031-X).

Potter, K.N. and Wilkin, T. J. (2000) The molecular specificity of insulin autoantibodies. Diabetes: Metabolism Research and Reviews, 16, (5), 338-353.

Primrose, J.N. (2000) Stomach and Duodenum. In, Bailey, Hamilton, Love, R.J. McNeill, Russell, R.C.G., Williams, N.S. and Bulstrode, C.J.K. (eds.) Bailey and Love's Short Practice of Surgery 23rd Edition. London, GB, Hodder Arnold, 891-930.

Protheroe, A.S., Pickard, C., Johnson, Peter W.M., Craddock, T., Shefta, J., Short, K., Lancaster, F., Selby, P. J., Henwood, J. and Boylston, A.W. (2000) Persistence of clonal T-cell expansions following high-dose chemotherapy and autologous peripheral blood progenitor cell rescue. British Jurnal of Haematology, 111, (3), 766-773.

Purohit, A., Hejaz, H.A., Walden, L., MacCarthy-Morrogh, L., Packham, G., Potter, B.V. and Reed, M.J. (2000) The effect of 2-methoxyoestrone-3-O-sulphamate on the growth of breast cancer cells and induced mammary tumours. International Journal of Cancer , 85, (4), 584-589. (doi:10.1002/(SICI)1097-0215(20000215)85:4<584::AID-IJC22>3.0.CO;2-Q).

Rahman, A., Stevenson , F.K. and Isenberg, D.A. (2000) B cells- formation and structure of autoantibodies. In, Gaston , J.S.H. (ed.) Rheumatic Diseases. Immunological Mechanisms and Prospects for New Therapies. Cambridge, GB, Cambridge University Press, 61-78.

Sahota, S.S., Davis, Z., Hamblin, T. J. and Stevenson, F. K. (2000) Somatic mutation of bcl-6 genes can occur in the absence of V(H) mutations in chronic lymphocytic leukemia. Blood, 95, (11), 3534-3540.

Simnett, S.J., Stewart, L. A., Sweetenham, J., Morgan, G. and Johnson, Peter W.M. (2000) Autologous stem cell transplantation for malignancy: a systematic review of the literature. Clinical and Laboratory Haematology, 22, (2), 61-72.

Stevenson, F., Zhu, D., Spellerberg, M.B., Rice, J., King, C.A., Thompsett, A.R., Sahota, S.S. and Hamblin, T.J. (2000) DNA vaccination against cancer antigens. Ernst Schering Foundation Symposium Proceedings, (30), 119-36.

Stevenson, Freda K., Zhu, Delin, Spellerberg, Myfanwy, King , Catherine A., Sahota , Surinder S., Rice, Jason, Thomsett , Andrew R. and Hamblin, Terry J. (2000) DNA Vaccines against B-cell tumors. In, Stern, Peter L., Beverley, Peter L.C. and Carroll, Miles W. (eds.) Cancer vaccines and immunotherapy. Cambridge, GB, Cambridge University Press, 218-236.

Webley, K, Bond, J A, Jones, C J, Blaydes, J P, Craig, A, Hupp, T and Wynford-Thomas, D (2000) Posttranslational modifications of p53 in replicative senescence overlapping but distinct from those induced by DNA damage. Molecular and Cellular Biology, 20, (8), 2803-2808.

This list was generated on Wed Aug 27 02:21:29 2014 BST.